Cleared Traditional

K950315 - CORDIS CSF RESERVOIR

K950315 is an FDA 510(k) clearance for CORDIS CSF RESERVOIR, manufactured by Cordis Corp.. The device is a Class 2 General Hospital device with product code LKG cleared through the Traditional 510(k) pathway after a 103-day FDA review.

K950315 · Cordis Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1995
Decision
103d
Days
Class 2
Risk

K950315 is an FDA 510(k) clearance for the CORDIS CSF RESERVOIR. Classified as Port & Catheter, Implanted, Subcutaneous, Intraventricular (product code LKG), Class II - Special Controls.

Submitted by Cordis Corp. (Miami, US). The FDA issued a Cleared decision on May 9, 1995 after a review of 103 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 882.5550 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Cordis Corp. devices

FDA 510(k) Submission Details - K950315

510(k) Number K950315 FDA.gov
FDA Decision Cleared Substantially Equivalent - Special 510(k) (SESK)
Date Received January 26, 1995
Decision Date May 09, 1995
Days to Decision 103 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 129d · This submission: 103d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LKG Device Classification - Class 2, Special Controls

Product Code LKG Port & Catheter, Implanted, Subcutaneous, Intraventricular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LKG Port & Catheter, Implanted, Subcutaneous, Intraventricular

Devices cleared under the same product code (LKG) and FDA review panel - the closest regulatory comparables to K950315.
PORT-A-CATH IMPLANTABLE ACCESS SYSTEM - KIT CONF.
K881493 · Pharmacia Deltec, Inc. · May 1988
PORT-A-CATH PORTAL INTRODUCER FORCEPS
K881690 · Pharmacia Deltec, Inc. · May 1988
P-S MEDICAL VENTRICULAR ACCESS PORT
K874468 · Pudenz-Schulte Medical Research Corp. · Feb 1988
CSF-VENTRICULOSTOMY RESERVOIR
K874498 · Pudenz-Schulte Medical Research Corp. · Feb 1988
P-S MEDICAL CSF ACCESS DEV 15MM/25MM
K833822 · Pudenz-Schulte Medical Research Corp. · May 1984
HH SUBCUTANEOUS ACCESS PORT
K833672 · Holter-Hausner Intl. · Mar 1984